Quick Heal Technologies (QUICKHEAL) investor relations material

Executive summary

• Q1 FY27 consolidated revenue was INR 44.99 crore, with EBITDA and PAT losses of INR 17.6 crore and INR 5.28 crore; enterprise wins continued amid consumer-market headwinds.

• Strategic priorities include enterprise expansion, AI-driven cybersecurity, new offerings, selective international growth and a broader integrated product stack.

• The Board approved unaudited consolidated and standalone results; auditors issued limited-review reports with unmodified conclusions.

Financial highlights

• Consolidated revenue was INR 44.99 crore versus INR 57.23 crore YoY and INR 48.73 crore QoQ, a 21.4% YoY decline.

• EBITDA loss was INR 17.6 crore versus INR 9.7 crore in Q1 FY26 and INR 29.3 crore in Q4 FY26; PAT loss was INR 5.28 crore versus INR 5.51 crore and INR 19.94 crore, respectively.

• Total income was INR 59.09 crore, including INR 14.10 crore of other income; PBT loss was INR 7.3 crore.

• Deferred revenue reached INR 52.3 crore versus INR 33.8 crore in Q4 FY26; the order book exceeded INR 56 crore, and incremental Q1 deferred revenue of INR 18.5 crore was cited as evidence of market acceptance.

• Overdues were INR 106.6 crore, reduced by nearly INR 70 crore since H1 FY26.

Outlook and guidance

• Priorities include expanding in large and mid-market customers, growing reach in India and select international geographies, and increasing wallet share through a holistic product stack.

• DPDP enforcement, new products and select international expansion were identified as drivers of serviceable obtainable market growth; FY27 priorities also include customer-centric innovation and sharper go-to-market execution.

• Enterprise roadmap includes government penetration, international expansion, data privacy market entry and commercialization of new products.